5 Ways Your Viral Vector Manufacturing Partner Should Make You Feel
With cell and gene therapies, you have the potential to transform the lives of patients — but with this potential come risks.
Whether you’re choosing a new CDMO or evaluating a current one, it can feel easier to assess the rational elements than it is to consider areas like everyday communications. Yet indicators that go beyond quality systems and logistics are just as important. Compare your current CDMO relationship against the following list, or use it in your evaluation of a new potential partner. If you answer no to more than two of these qualities, it might be time to have a frank discussion with your program manager.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.